478 related articles for article (PubMed ID: 26243045)
21. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
22. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.
Nakajima K; Oshida H; Muneyuki T; Kakei M
Core Evid; 2012; 7():77-91. PubMed ID: 22936895
[TBL] [Abstract][Full Text] [Related]
23. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
Roberts KJ; Bannister CA; Schrem H
Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
[TBL] [Abstract][Full Text] [Related]
24. [The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study].
Bideeva TV; Maev IV; Kucheryavyy YA; Andreev DN; Shah YS; Lobanova EG; Zaborovskiy AV; Levchenko AI
Ter Arkh; 2020 Jan; 92(1):30-35. PubMed ID: 32598660
[TBL] [Abstract][Full Text] [Related]
25. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
26. Yield of testing for micronutrient deficiencies associated with pancreatic exocrine insufficiency in a clinical setting: An observational study.
Jalal M; Campbell JA; Tesfaye S; Al-Mukhtar A; Hopper AD
World J Clin Cases; 2021 Dec; 9(36):11320-11329. PubMed ID: 35071562
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency.
Caras S; Boyd D; Zipfel L; Sander-Struckmeier S
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):634-40. PubMed ID: 21681115
[TBL] [Abstract][Full Text] [Related]
28. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease.
Shintakuya R; Uemura K; Murakami Y; Kondo N; Nakagawa N; Urabe K; Okano K; Awai K; Higaki T; Sueda T
Pancreatology; 2017; 17(1):70-75. PubMed ID: 27743711
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic enzyme supplementation.
Wier HA; Kuhn RJ
Curr Opin Pediatr; 2011 Oct; 23(5):541-4. PubMed ID: 21799412
[TBL] [Abstract][Full Text] [Related]
30. Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
Borowitz D; Stevens C; Brettman LR; Campion M; Wilschanski M; Thompson H;
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):248-57. PubMed ID: 22266487
[TBL] [Abstract][Full Text] [Related]
31. Pancrelipase for pancreatic disorders: An update.
Dhanasekaran R; Toskes PP
Drugs Today (Barc); 2010 Nov; 46(11):855-66. PubMed ID: 21225024
[TBL] [Abstract][Full Text] [Related]
32. Exocrine Pancreas Dysfunction in Type 1 Diabetes.
Foster TP; Bruggeman B; Campbell-Thompson M; Atkinson MA; Haller MJ; Schatz DA
Endocr Pract; 2020 Dec; 26(12):1505-1513. PubMed ID: 33471743
[TBL] [Abstract][Full Text] [Related]
33. Less common etiologies of exocrine pancreatic insufficiency.
Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM
World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615
[TBL] [Abstract][Full Text] [Related]
34. Metabolic markers of protein maldigestion after a
Mary F; Moesseler A; Khodorova N; Foucault-Simonin A; Benamouzig R; Tomé D; Gregory PC; Gaudichon C
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G223-G230. PubMed ID: 29074486
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic exocrine insufficiency, diabetes mellitus and serum nutritional markers after acute pancreatitis.
Vujasinovic M; Tepes B; Makuc J; Rudolf S; Zaletel J; Vidmar T; Seruga M; Birsa B
World J Gastroenterol; 2014 Dec; 20(48):18432-8. PubMed ID: 25561813
[TBL] [Abstract][Full Text] [Related]
36. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis.
Hall LA; Powell-Brett S; Halle-Smith J; Ward L; Wiggins T; Markar SR; Roberts KJ
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38064682
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic enzyme pharmacotherapy.
Ferrone M; Raimondo M; Scolapio JS
Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
[TBL] [Abstract][Full Text] [Related]
39. Medical nutrition therapy for cystic fibrosis: beyond pancreatic enzyme replacement therapy.
Hayek KM
J Am Diet Assoc; 2006 Aug; 106(8):1186-8. PubMed ID: 16863713
[No Abstract] [Full Text] [Related]
40. Pancreatic enzyme replacement therapy in chronic pancreatitis.
Sikkens EC; Cahen DL; Kuipers EJ; Bruno MJ
Best Pract Res Clin Gastroenterol; 2010 Jun; 24(3):337-47. PubMed ID: 20510833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
